Product Details
Product Name:
MBCQ |
CAS No.:
150450-53-6 |
Purity:
99.45% |
Supply Ability:
10g |
Release date:
2024/11/18 |
Product Introduction
Bioactivity
Name | MBCQ |
Description | MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5. |
In vitro | MBCQ, a selective PDE5 inhibitor, significantly decreased the EC(50) values for GTN-induced relaxation in both tolerant and nontolerant tissues, but with the greatest relative shift occurring in tolerant veins[1]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 25 mg/mL (79.68 mM)
|
Keywords | cGMP-PDE | inhibit | arteries | PGF2α | Inhibitor | MBCQ | Phosphodiesterase (PDE) | coronary |
Inhibitors Related | Theophylline monohydrate | Diphylline | Acefylline | Roflumilast | Theobromine | Apremilast | Isoprenaline hydrochloride | Indomethacin | Icariin | Theophylline | Vardenafil hydrochloride | Doxofylline |
Related Compound Libraries | 經(jīng)典已知活性庫 | 抑制劑庫 | NO PAINS 化合物庫 | 抗心血管疾病化合物庫 | 代謝化合物庫 | 已知活性化合物庫 | 抗代謝疾病化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:332-80-9
$40.00 / 5mg
-
CAS:6681-13-6
$372.00 / 5mg
-
CAS:139-85-5
$30.00 / 50mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |